HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Response of the rat intestinal microcirculation to experimental endotoxemia is attenuated by ampicillin but not by its derivative KKP723.

Abstract
KKP723 (KKP), a derivative of ampicillin, is a newly developed beta-lactam antibiotic. Using an experimental endotoxemia model, the intestinal microcirculation in four groups of animals were evaluated using intravital microscopy (IVM). The groups included were a control group, an endotoxemic group (15 mg/kg i.v. LPS from E. coli), an ampicillin (50 mg/kg i.v.) treated endotoxemic group and an endotoxemic group treated with KKP (67.4 mg/kg i.v.). Ampicillin treatment resulted in a significant reduced number of firmly adhering leukocytes in intestinal submucosal venules. KKP treatment did not show this effect on leukocyte activation. We found no changes of the functional capillary density (FCD) of the intestinal wall by treatment with ampicillin or its derivative KKP. The increased leukocyte adherence in the KKP treated LPS animals may be explained by a loss of a possible ampicillin-related anti-inflammatory effect by the biotransformation process. The endotoxemia IVM model is useful to detect effects of antibiotics in an impaired microcirculation.
AuthorsM Gründling, Ch Lehmann, D Saeger, S Bohnenstengel, D Pavlovic, V Bac, T Usichenko, K Meissner, M Wendt, O Hung, M Murphy, S Whynot, U Lindequist
JournalClinical hemorheology and microcirculation (Clin Hemorheol Microcirc) Vol. 38 Issue 3 Pg. 163-70 ( 2008) ISSN: 1386-0291 [Print] Netherlands
PMID18239258 (Publication Type: Journal Article)
Chemical References
  • KKP723
  • Lipopolysaccharides
  • Ampicillin
Topics
  • Ampicillin (analogs & derivatives, pharmacology)
  • Animals
  • Disease Models, Animal
  • Endotoxemia (physiopathology)
  • Intestinal Mucosa (blood supply, drug effects)
  • Intestines (blood supply)
  • Lipopolysaccharides (toxicity)
  • Male
  • Microcirculation (drug effects)
  • Rats
  • Rats, Inbred Lew

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: